France – Bêta-bloquants – Fourniture des traitements nécessaires à l’étude BOLERO
AI summary
This tender concerns the supply of beta-blocker medications required for the BOLERO clinical study. The Centre Hospitalier Régional Universitaire de Tours seeks a qualified supplier to provide pharmaceutical treatments meeting the study's specifications.
Pharmaceutical distributors or suppliers licensed to distribute beta-blocker medications in France with experience supplying clinical research institutions.
Suppliers must be authorized pharmaceutical distributors with capability to supply beta-blockers in conformance with clinical trial requirements. Compliance with French and EU pharmaceutical regulations and quality standards is mandatory.
Frequently asked questions
What is this tender about?
This tender concerns the supply of beta-blocker medications required for the BOLERO clinical study. The Centre Hospitalier Régional Universitaire de Tours seeks a qualified supplier to provide pharmaceutical treatments meeting the study's specifications.
What are the requirements for suppliers?
Suppliers must be authorized pharmaceutical distributors with capability to supply beta-blockers in conformance with clinical trial requirements. Compliance with French and EU pharmaceutical regulations and quality standards is mandatory.
What type of company should bid?
Pharmaceutical distributors or suppliers licensed to distribute beta-blocker medications in France with experience supplying clinical research institutions.
Who is the buyer?
The buyer is CENTRE HOSPITALIER REG UNVT DE TOURS.
When does this tender close?
Submissions close on September 4, 2026.
Fourniture des traitements nécessaires à l’étude BOLERO
Fourniture des traitements nécessaires à l’étude BOLERO
Scoring criteria not specified
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…